These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7459332)

  • 1. Solution conformation of thymopoietin32-36: a proton nuclear magnetic resonance study.
    Krishna NR; Huang DH; Chen DM; Goldstein G
    Biochemistry; 1980 Nov; 19(24):5557-63. PubMed ID: 7459332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton nuclear magnetic resonance study of an active pentapeptide fragment of ubiquitin.
    Krishna NR; Huang DH; Vaughn JB; Heavner GA; Goldstein G
    Biochemistry; 1981 Jun; 20(13):3933-40. PubMed ID: 6268154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton NMR investigation of Ln3+ complexes of thymopoietin 32-36.
    Vaughn JB; Stephens RL; Lenkinski RE; Krishna NR; Heavner GA; Goldstein G
    Biochim Biophys Acta; 1981 Nov; 671(1):50-60. PubMed ID: 7030403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformational properties of the pentapeptide fragment [32-36] of the thymic hormone thymopoietin.
    Tourwé D; De Coen JL; Hallenga K; Van Binst G
    Int J Pept Protein Res; 1984 Jan; 23(1):84-93. PubMed ID: 6365814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short in vitro half-life of thymopoietin32--36 pentapeptide in human plasma.
    Tischio JP; Patrick JE; Weintraub HS; Chasin M; Goldstein G
    Int J Pept Protein Res; 1979; 14(5):479-84. PubMed ID: 395119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1H-NMR studies on thymopoietin-type oligopeptides--assignment of the proton resonances and investigation of conformational preferences.
    Guo W; Noszál B; Schön I; Nyéki O
    J Pharm Biomed Anal; 1993 Jul; 11(7):541-7. PubMed ID: 8399527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear magnetic resonance analysis of Gd3+-induced perturbations in thymopoietin 32-36: a study of amide and aromatic proton resonances.
    Vaughn JB; Stephens RL; Lenkinski RE; Heavner GA; Goldstein G; Krishna NR
    Arch Biochem Biophys; 1982 Sep; 217(2):468-72. PubMed ID: 6753747
    [No Abstract]   [Full Text] [Related]  

  • 8. NMR study of thymulin, a lymphocyte differentiating thymic nonapeptide. Conformational states of free peptide in solution.
    Laussac JP; Cung MT; Pasdeloup M; Haran R; Marraud M; Lefrancier P; Dardenne M; Bach JF
    J Biol Chem; 1986 Jun; 261(17):7784-90. PubMed ID: 3711109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton NMR studies of angiotensin II and its analogs in aqueous solution.
    Zhou N; Moore GJ; Vogel HJ
    J Protein Chem; 1991 Jun; 10(3):333-43. PubMed ID: 1910465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amide hydrogen exchange rates of peptides in H2O solution by 1H nuclear magnetic resonance transfer of solvent saturation method. Conformations of oxytocin and lysine vasopressin in aqueous solution.
    Krishna NR; Huang DH; Glickson JD; Rowan R; Walter R
    Biophys J; 1979 Jun; 26(3):345-66. PubMed ID: 262422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformational analysis of a cyclic thymopoietin-analogue by 1H n.m.r. spectroscopy and restrained molecular dynamics simulations.
    Lautz J; Kessler H; Boelens R; Kaptein R; van Gunsteren WF
    Int J Pept Protein Res; 1987 Sep; 30(3):404-14. PubMed ID: 3692686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biologically active analogs of thymopentin with enhanced enzymatic stability.
    Heavner GA; Kroon DJ; Audhya T; Goldstein G
    Peptides; 1986; 7(6):1015-9. PubMed ID: 3031628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Conformation states of thymopentin and its synthetic analogs].
    Akhmedov NA; Khalilova NM; Popov EM
    Mol Biol (Mosk); 1987; 21(1):159-63. PubMed ID: 3553894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformation of angiotensin II. Evidence for a specific hydrogen bonded conformation.
    Lenkinski RE; Stephens RL; Krishna NR
    Biochemistry; 1981 May; 20(11):3122-6. PubMed ID: 7248274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of a novel thymopoietin analogue based on conformational analyses.
    Solmajer T
    Drug Des Deliv; 1990 Sep; 6(3):213-21. PubMed ID: 2076180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformation of cobrotoxin in aqueous solution as studied by nuclear magnetic resonance.
    Endo T; Inagaki F; Hayashi K; Miyazawa T
    Eur J Biochem; 1979 Dec; 102(2):417-30. PubMed ID: 43248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solution conformation of a model hexapeptide containing RGD sequence.
    Dhingra MM
    Indian J Biochem Biophys; 1992 Dec; 29(6):458-64. PubMed ID: 1294461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of thymic hormones on mitogen-induced interferon production in lymphocytes. II. Enhancement of Con-A-induced immune interferon production by a synthetic thymopoietin pentapeptide.
    Rentz E; Diezel W; Ehrlich A; Forner K
    Arch Geschwulstforsch; 1984; 54(2):113-8. PubMed ID: 6329122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical synthesis and application of C-terminally 5-carboxyfluorescein-labelled thymopentin as a fluorescent probe for thymopoietin receptor.
    Onoue S; Liu B; Nemoto Y; Hirose M; Yajima T
    Anal Sci; 2006 Dec; 22(12):1531-5. PubMed ID: 17159311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of new thymopoietin derivatives on the immune response of inbred mice.
    Rajnavölgyi E; Kulics J; Szilágyvári M; Kisfaludy L; Nyéki O; Schön I; Gergely J
    Int J Immunopharmacol; 1986; 8(2):167-77. PubMed ID: 3519478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.